BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 14,400 Value ($000) $112 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 46,800 Value ($000) $355 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 88,400 Value ($000) $792 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 88,400 Value ($000) $663 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 88,400 Value ($000) $665 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 88,400 Value ($000) $672 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 88,400 Value ($000) $546 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 88,400 Value ($000) $449 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 92,860 Value ($000) $556 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 92,860 Value ($000) $657 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 92,860 Value ($000) $654 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 92,860 Value ($000) $774 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 81,560 Value ($000) $936 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 53,360 Value ($000) $672 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 51,830 Value ($000) $548 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 51,830 Value ($000) $843 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 51,830 Value ($000) $718 Avg Close $13.23 Range $10.72 - $15.77